Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
Lifespan extension is the most attention-grabbing finding in fisetin research. The 2018 Yousefzadeh et al. study showed that late-life fisetin treatment extended both median and maximum lifespan in naturally aging mice by approximately 10%. This page examines the lifespan evidence, the NIA Interventions Testing Program context, the translational limitations, and why mouse lifespan findings rarely translate to human longevity. No human evidence supports fisetin for extending human lifespan.
Lifespan Research Is Fascinating — But Your Cells Need Support Now
Human longevity studies take decades. Your mitochondria need help today. Give them the cellular renewal protocol science is just beginning to understand.
Detailed Evidence
THE YOUSEFZADEH 2018 LIFESPAN STUDY The landmark 2018 EBioMedicine study (Yousefzadeh et al.) demonstrated that fisetin, among 10 flavonoids tested, was the most potent senolytic. In the lifespan experiment: naturally aging mice received fisetin-supplemented diet starting at 85 weeks (approximately 75 human years); treatment continued for the remainder of life; fisetin reduced senescence markers (p16Ink4a, p21, SA-β-gal) in adipose, liver, kidney, and brain; and both median and maximum lifespan were extended by approximately 10%. This single study generated enormous excitement in the aging research community and catalyzed much of the subsequent fisetin research and commercial interest. THE NIA INTERVENTIONS TESTING PROGRAM (ITP) The NIA ITP is the gold standard for lifespan testing — a rigorous multi-site program that tests compounds for lifespan extension in genetically heterogeneous mice. Compounds that pass ITP testing (rapamycin, acarbose, 17α-estradiol, canagliflozin) have strong translational credibility. Fisetin has NOT been tested by the ITP as of 2026. The Yousefzadeh study was conducted in a single laboratory with a single mouse strain — far less rigorous than ITP testing. WHY MOUSE LIFESPAN FINDINGS RARELY TRANSLATE The translation rate from mouse lifespan to human longevity is very poor: most compounds that extend mouse lifespan fail to show benefit in human studies; mouse aging biology differs from human aging in metabolism, telomere biology, and disease patterns; the doses used in mouse studies may not be achievable or safe in humans; single-laboratory findings often fail replication; and lifespan is a complex, multifactorial endpoint influenced by genetics, environment, and chance. REPLICATION STATUS As of 2026, the Yousefzadeh 2018 lifespan finding has NOT been independently replicated by a separate research group. Replication is essential before any lifespan claim can be considered reliable. The ITP has not tested fisetin. Without replication and ITP testing, the lifespan finding remains preliminary. HUMAN LONGEVITY: NO EVIDENCE No human trial has measured lifespan, healthspan, or biological aging rate with fisetin. Human lifespan studies would take decades. The ongoing frailty and vascular trials may provide early functional data, but no trial is designed to measure longevity endpoints. WHAT ACTUALLY EXTENDS HUMAN HEALTHSPAN Human healthspan (healthy years) is best supported by evidence-based interventions: regular exercise (the single strongest lifestyle factor for longevity); Mediterranean or similar dietary patterns; maintaining healthy weight; not smoking; moderate alcohol (or none); adequate sleep (7-9 hours); strong social connections; managing blood pressure, cholesterol, and blood sugar; and preventive healthcare. No supplement, including fisetin, has proven lifespan extension in humans. COMMERICAL LONGEVITY CLAIMS Many fisetin supplements are marketed with implied longevity benefits. These claims are not supported by human evidence. The mouse lifespan study is interesting science but not evidence of human longevity benefit. Consumers should be skeptical of any supplement marketed for 'anti-aging' or 'longevity.'
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
The Reason 90% of Anti-Aging Supplements Don't Work
They target symptoms, not the root cause: cellular energy decline. ReCellence targets the mitochondria directly.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
Does fisetin extend lifespan?
In the 2018 Yousefzadeh study, fisetin extended remaining lifespan in naturally aging mice by approximately 10%. No human evidence supports fisetin for extending human lifespan.
Has fisetin been tested by the NIA ITP?
No. The NIA Interventions Testing Program (gold standard for lifespan testing) has not tested fisetin as of 2026. The Yousefzadeh study was a single-laboratory finding, far less rigorous than ITP testing.
Is fisetin an anti-aging supplement?
No human evidence supports fisetin for anti-aging or longevity. The mouse lifespan finding is interesting science but not evidence of human benefit. Be skeptical of 'anti-aging' supplement claims.
Has the fisetin lifespan finding been replicated?
As of 2026, the Yousefzadeh 2018 lifespan finding has not been independently replicated by a separate research group. Replication is essential before any lifespan claim can be considered reliable.
Why don't mouse lifespan findings translate to humans?
Mouse and human aging differ in metabolism, telomere biology, and disease patterns. Most compounds extending mouse lifespan fail in human studies. Single-laboratory findings often fail replication. Lifespan is complex and multifactorial.
How much did fisetin extend lifespan in mice?
Approximately 10% extension of both median and maximum remaining lifespan in naturally aging mice treated late in life (starting at ~75 human-equivalent years).
What is the NIA Interventions Testing Program?
The ITP is the gold standard for lifespan testing — a rigorous multi-site program. Compounds passing ITP (rapamycin, acarbose, 17α-estradiol, canagliflozin) have strong translational credibility. Fisetin has not been ITP-tested.
Can fisetin make you live longer?
No human evidence supports fisetin for extending human lifespan. Human lifespan studies would take decades. No supplement, including fisetin, has proven lifespan extension in humans.
What actually extends human healthspan?
Regular exercise (strongest lifestyle factor), Mediterranean diet, healthy weight, not smoking, adequate sleep, strong social connections, managing blood pressure/cholesterol/blood sugar, and preventive healthcare.
Are fisetin longevity supplements worth buying?
No fisetin supplement has proven longevity benefit in humans. Claims are based on a single mouse study. Be skeptical of any supplement marketed for 'anti-aging' or 'longevity.'
What is healthspan vs lifespan?
Lifespan is total years lived. Healthspan is healthy, functional years. Extending healthspan (more healthy years) is arguably more valuable than extending total lifespan. No supplement has proven healthspan extension in humans.
How old were the mice in the lifespan study?
Mice were 85 weeks old (approximately 75 human-equivalent years) when fisetin treatment began, modeling late-life intervention. Treatment continued for the remainder of life.
Is exercise better than fisetin for longevity?
Yes. Exercise has the strongest evidence base for human longevity and healthspan of any lifestyle factor. Fisetin has a single mouse study. There is no comparison.
What is rapamycin and how does it compare?
Rapamycin is an ITP-validated lifespan-extending compound with robust evidence. Unlike fisetin, rapamycin has passed rigorous multi-site testing. Fisetin's evidence is far less rigorous.
Should I take fisetin for longevity?
No human evidence supports fisetin for human longevity. Focus on evidence-based healthspan interventions: exercise, diet, sleep, social connection, and preventive healthcare. Consult a qualified healthcare provider.
Key Research Facts
Late-life fisetin treatment extended remaining lifespan in naturally aging mice by approximately 10% (median and maximum).
Strong EvidenceYousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015
Fisetin was the most potent senolytic among 10 flavonoids tested in the 2018 Yousefzadeh study.
Strong EvidenceYousefzadeh et al., EBioMedicine — doi:10.1016/j.ebiom.2018.09.015
The NIA Interventions Testing Program (gold standard) has NOT tested fisetin as of 2026 — the lifespan finding lacks ITP validation.
Strong EvidenceNIA ITP — https://www.nia.nih.gov/research/itp
The Yousefzadeh 2018 lifespan finding has not been independently replicated by a separate research group as of 2026.
Strong EvidenceLiterature review — PubMed search, 2026
Most compounds that extend mouse lifespan fail to show benefit in human studies — the mouse-to-human translation rate is very poor.
Strong EvidenceAging research — NIA ITP historical data
No human trial has measured lifespan, healthspan, or biological aging rate with fisetin as of 2026.
Strong EvidenceClinicalTrials.gov / PubMed — registry + literature search
Exercise has the strongest evidence base for human longevity and healthspan of any lifestyle factor.
Strong EvidenceLongevity research — Multiple systematic reviews
ITP-validated lifespan compounds (rapamycin, acarbose, 17α-estradiol, canagliflozin) have far stronger translational credibility than fisetin.
Strong EvidenceNIA ITP publications — Multiple landmark studies
Human lifespan studies would take decades — no supplement, including fisetin, has proven lifespan extension in humans.
Strong EvidenceLongevity research consensus — Literature review
Mediterranean diet, healthy weight, not smoking, adequate sleep, and strong social connections have strong evidence for human healthspan.
Strong EvidenceLongevity research — Multiple large cohort studies
Citations & External Resources
EBioMedicine — Yousefzadeh et al. 2018 (Fisetin Lifespan)
NIA Interventions Testing Program
ClinicalTrials.gov — Search: Fisetin
PubMed — Fisetin research
J Internal Medicine — Kirkland & Tchkonia 2020 (Senolytic Translation)
Lancet — Exercise and Longevity Review
What If Your Afternoon Energy Crash Isn't About Sleep?
New research points to mitochondrial dysfunction as the hidden driver of chronic fatigue. Here's what you can do about it today.
Related Reading
Fisetin: The Complete Evidence-Based Guide
Fisetin & Healthy Aging: What Research Shows
How Fisetin Works: Senolytic Mechanisms
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026